Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults

Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage, Lise Sofie Nissen-Meyer, Unni C. Nygaard, Olav Hungnes, Anna H Robertson, Lisbeth Meyer Næss, Lill Trogstad, Per Magnus, Ludvig A Munthe, Siri Mjaaland
doi: https://doi.org/10.1101/2022.01.13.22269213
Hassen Kared
1KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo
2Department of Immunology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hassen.kared@medisin.uio.no l.a.munthe@medisin.uio.no
Asia-Sophia Wolf
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amin Alirezaylavasani
1KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Ravussin
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guri Solum
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trung The Tran
2Department of Immunology, Oslo University Hospital, Oslo, Norway
4ImmunoLingo Convergence Center, Institute of Clinical medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fridtjof Lund-Johansen
2Department of Immunology, Oslo University Hospital, Oslo, Norway
4ImmunoLingo Convergence Center, Institute of Clinical medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Torgils Vaage
2Department of Immunology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise Sofie Nissen-Meyer
2Department of Immunology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Unni C. Nygaard
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olav Hungnes
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna H Robertson
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisbeth Meyer Næss
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lill Trogstad
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Magnus
5Center for Fertility and Health, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludvig A Munthe
1KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo
2Department of Immunology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hassen.kared@medisin.uio.no l.a.munthe@medisin.uio.no
Siri Mjaaland
3Division of Infection Control, Norwegian Institute of Public Health, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
PreviousNext
Posted January 13, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults
Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage, Lise Sofie Nissen-Meyer, Unni C. Nygaard, Olav Hungnes, Anna H Robertson, Lisbeth Meyer Næss, Lill Trogstad, Per Magnus, Ludvig A Munthe, Siri Mjaaland
medRxiv 2022.01.13.22269213; doi: https://doi.org/10.1101/2022.01.13.22269213
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults
Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage, Lise Sofie Nissen-Meyer, Unni C. Nygaard, Olav Hungnes, Anna H Robertson, Lisbeth Meyer Næss, Lill Trogstad, Per Magnus, Ludvig A Munthe, Siri Mjaaland
medRxiv 2022.01.13.22269213; doi: https://doi.org/10.1101/2022.01.13.22269213

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (162)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (863)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8571)
  • Forensic Medicine (4)
  • Gastroenterology (388)
  • Genetic and Genomic Medicine (1759)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1249)
  • Health Policy (622)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (378)
  • Infectious Diseases (except HIV/AIDS) (10318)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (213)
  • Neurology (1682)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (328)
  • Occupational and Environmental Health (451)
  • Oncology (930)
  • Ophthalmology (264)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (538)
  • Pharmacology and Therapeutics (254)
  • Primary Care Research (209)
  • Psychiatry and Clinical Psychology (1775)
  • Public and Global Health (3853)
  • Radiology and Imaging (626)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (521)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)